Impact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC: A systematic review and meta-analysis

U. Dafni; R. A. Soo; S. Peters; Z. Tsourti; K. Vervita; J-Y. Han; J. De Castro; L. Coate; M. Frueh; S. M. S. Hashemi; E. Nadal; E. Carcereny; M. Angeles Sala Gonzalez; R. Bernabe Caro; M. Provencio Pulla; S. Cuffe; B. Ruepp; H. Roschitzki-Voser; R. Rosell; R. A. Stahel

doi:https://doi.org/10.1016/j.annonc.2022.02.041

Impact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC: A systematic review and meta-analysis

U. Dafni, R. A. Soo, S. Peters, Z. Tsourti, K. Vervita, J-Y. Han, J. De Castro, L. Coate, M. Frueh, S. M. S. Hashemi, E. Nadal, E. Carcereny, M. Angeles Sala Gonzalez, R. Bernabe Caro, M. Provencio Pulla, S. Cuffe, B. Ruepp, H. Roschitzki-Voser, R. Rosell, R. A. Stahel

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	S46-S47
Journal	Annals of Oncology
Volume	33
DOIs	https://doi.org/10.1016/j.annonc.2022.02.041
Publication status	Published - Apr 2022

Access to Document

https://doi.org/10.1016/j.annonc.2022.02.041

Cite this

Dafni, U., Soo, R. A., Peters, S., Tsourti, Z., Vervita, K., Han, J.-Y., De Castro, J., Coate, L., Frueh, M., Hashemi, S. M. S., Nadal, E., Carcereny, E., Sala Gonzalez, M. A., Bernabe Caro, R., Provencio Pulla, M., Cuffe, S., Ruepp, B., Roschitzki-Voser, H., Rosell, R., & Stahel, R. A. (2022). Impact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC: A systematic review and meta-analysis. Annals of Oncology, 33, S46-S47. https://doi.org/10.1016/j.annonc.2022.02.041

@article{b68516601f2547b5b8f8ca42c71017be,

title = "Impact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC: A systematic review and meta-analysis",

author = "U. Dafni and Soo, {R. A.} and S. Peters and Z. Tsourti and K. Vervita and J-Y. Han and {De Castro}, J. and L. Coate and M. Frueh and Hashemi, {S. M. S.} and E. Nadal and E. Carcereny and {Sala Gonzalez}, {M. Angeles} and {Bernabe Caro}, R. and {Provencio Pulla}, M. and S. Cuffe and B. Ruepp and H. Roschitzki-Voser and R. Rosell and Stahel, {R. A.}",

year = "2022",

month = apr,

doi = "https://doi.org/10.1016/j.annonc.2022.02.041",

language = "English",

volume = "33",

pages = "S46--S47",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Dafni, U, Soo, RA, Peters, S, Tsourti, Z, Vervita, K, Han, J-Y, De Castro, J, Coate, L, Frueh, M, Hashemi, SMS, Nadal, E, Carcereny, E, Sala Gonzalez, MA, Bernabe Caro, R, Provencio Pulla, M, Cuffe, S, Ruepp, B, Roschitzki-Voser, H, Rosell, R & Stahel, RA 2022, 'Impact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC: A systematic review and meta-analysis', Annals of Oncology, vol. 33, pp. S46-S47. https://doi.org/10.1016/j.annonc.2022.02.041

TY - JOUR

T1 - Impact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC: A systematic review and meta-analysis

AU - Dafni, U.

AU - Soo, R. A.

AU - Peters, S.

AU - Tsourti, Z.

AU - Vervita, K.

AU - Han, J-Y.

AU - De Castro, J.

AU - Coate, L.

AU - Frueh, M.

AU - Hashemi, S. M. S.

AU - Nadal, E.

AU - Carcereny, E.

AU - Sala Gonzalez, M. Angeles

AU - Bernabe Caro, R.

AU - Provencio Pulla, M.

AU - Cuffe, S.

AU - Ruepp, B.

AU - Roschitzki-Voser, H.

AU - Rosell, R.

AU - Stahel, R. A.

PY - 2022/4

Y1 - 2022/4

U2 - https://doi.org/10.1016/j.annonc.2022.02.041

DO - https://doi.org/10.1016/j.annonc.2022.02.041

M3 - Meeting Abstract

SN - 0923-7534

VL - 33

SP - S46-S47

JO - Annals of Oncology

JF - Annals of Oncology

ER -